Laurion Capital Management LP - CYTEIR THERAPEUTICS INC ownership

Quarter-by-quarter ownership
Laurion Capital Management LP ownership history of CYTEIR THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,020,980
+9.2%
359,5000.0%0.01%
+20.0%
Q2 2023$934,700
+42.9%
359,5000.0%0.01%
+25.0%
Q1 2023$654,290
+10.3%
359,5000.0%0.00%
+33.3%
Q4 2022$593,175
-14.0%
359,5000.0%0.00%
-25.0%
Q3 2022$690,000
-35.8%
359,5000.0%0.00%
-76.5%
Q2 2022$1,075,000359,5000.02%
Other shareholders
CYTEIR THERAPEUTICS INC shareholders Q4 2023
NameSharesValueWeighting ↓
Novo Holdings A/S 4,840,413$84,949,0004.39%
ACUTA CAPITAL PARTNERS, LLC 391,974$6,879,0002.43%
Ally Bridge Group (NY) LLC 319,538$5,608,0001.65%
RA Capital Management 3,350,506$58,801,0000.82%
Avidity Partners Management LP 1,683,441$29,544,0000.66%
Sofinnova Investments, Inc. 246,321$4,323,0000.26%
CAAS CAPITAL MANAGEMENT LP 579,746$10,175,0000.20%
SPHERA FUNDS MANAGEMENT LTD. 135,145$2,372,0000.20%
ACT CAPITAL MANAGEMENT, LLC 15,000$263,0000.14%
Baker Brothers Advisors 812,640$14,262,0000.06%
View complete list of CYTEIR THERAPEUTICS INC shareholders